Drug Database
Back to search

Poland· PL-100335068

Vizitrav

A travoprost product containing travoprostum, registered in Poland by Bausch+Lomb Ireland Ltd.. The same ATC class is registered in 18 of our 19 countries.

ATC S01EE04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVizitravATCS01EE04REGISTER NO.PL-100335068PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about travoprostumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Travoprost is registered in 18 of 19 countries.

Countries holding a registration under ATC S01EE04 (travoprost), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose
Search travoprost products by name

Travoprost · ATC S01EE04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Travoprostum
Manufacturer
Bausch+Lomb Ireland Ltd.
Country
Poland (PL)
ATC code
S01EE04
ATC class
Travoprost
Defined daily dose
0.1 ml, AT
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991321956
  • gtin
    05909991321949
  • gtin
    05397258000445

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

70 interactions on record for travoprost.

Graded by severity as the source publishes them — 70 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check travoprost against other medicinesHow interaction checks work

Travoprost · interactions on record

70 records

  • 70 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Travoprost in 17 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All travoprost products

    Authorised across Europe · EMA

    The same active substance is authorised in 27 EEA countries. Names it is sold under:

    • Austria · Fredomat, Traglasin
    • Belgium · Travoprost Eg, Vizitrav
    • Bulgaria · Даверис, Травапрес
    • Cyprus · Trav-Iop (Preservative Free), Travoprost Rafarm
    • Czechia · Bondulc, Fredomat
    • Germany · Fredomat, Travaprost Ratiopharm
    • Denmark · Stavorio, Traglafka
    • Estonia · Travoprost Elvim, Travoprost Zentiva
    • Spain · Leachim, Sinetrav
    • Finland · Travoprost Stada
    • France · Sinetrav, Traglasin
    • United Kingdom (Northern Ireland) · Travoprost Accord-Uk, Travoprost Aspire Pharma
    • Greece · Stavorio, Trav-Iop
    • Croatia · Vizitrav
    • Iceland · Izba, Travatan
    • Italy · Acamba, Brunitrav
    • Liechtenstein · Izba, Travatan
    • Lithuania · Traslor, Travoprost Elvim
    • Luxembourg · Travoprost Eg, Vizitrav
    • Latvia · Traslor, Travoprost Elvim
    • Malta · Travic
    • Netherlands · Leachim, Travapress
    • Norway · Izba, Travatan
    • Portugal · Travoprost Ciclum, Travoprost Rafarm
    • Romania · Travapress, Travoprost Zentiva
    • Sweden · Bondulc, Travoprost Medical Valley
    • Slovakia · Travoprost Olikla

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/235ce358-469f-46f8-a749-cb5f690b4ffd
GET /v1/drugs/235ce358-469f-46f8-a749-cb5f690b4ffd?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Krople do oczu, roztwór",
  "source": "urpl",
  "strength": "0,04 mg",
  "packaging": "05909991321949 ¦ Rp ¦ 121106\n1 poj. 2,5 ml\n05909991321956 ¦ Rp ¦ 121107\n3 poj. 2,5 ml\n05397258000445 ¦ Rp ¦ 147621\n4 poj. 2,5 ml",
  "substance": "Travoprostum 0.04 mg",
  "common_name": "Travoprostum",
  "pl_product_id": "100335068",
  "pozwolenie_nr": "23844",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
    API referenceMCP serverPlans

    See everything about travoprost.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console